Among the poster presentations was Accelerating Evidence Generation by Convening Diverse Stakeholders Across the Real World Data Ecosystem.  It details how the Reagan-Udall Foundation for the FDA, in collaboration with Friends of Cancer Research and active participation by FDA and key stakeholders, launched the COVID-19 Evidence Accelerator in April 2020. This model may be adapted to address other urgent public health challenges where collaborative scientific analyses using real-world data could enhance understanding. 

Another presentation focused on Convening Stakeholders Across the Real-World Data Ecosystem, which also highlighted the work of the COVID-19 Evidence Accelerator. The poster explains how the Evidence Accelerator creates a strong foundation for rapid collection and rigorous analysis of RWD to answer urgent questions about COVID-19.